A case that explores the impact of financial incentives from insurance companies on the patient-physician relationship and whether or not they should be disclosed to a patient.
An ethical case describes the use of a pharmacy's database to market directly to their patients without either patient consent or disclosure of the marketing intent of the materials they received.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.
Physicians need to be aware of the legal and ethical issues raised by genetic information and technology, as evidenced by three court rulings dealing with prenatal testing and a family predisposition to genetic genetically transferred illness.